$48.64
+1.15 (+2.42%)
Performance
1D
—
1W
—
1M
—
3M
+47.17%
6M
+80.15%
1Y
+16.14%
YTD
+50.17%
Open$48.82
Previous Close$47.49
Day High$50.82
Day Low$48.48
52W High$57.88
52W Low$23.30
Volume—
Avg Volume933.9K
Market Cap2.65B
P/E Ratio—
EPS$-1.27
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$39.72
Above
SMA 200
$33.17
Above
RSI (14)
70
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+47.2% upside
Current
$48.64
$48.64
Target
$71.60
$71.60
$49.68
$71.60 avg
$88.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 386.04M | 314.49M | 1.46B |
| Net Income | -79,625,511 | -58,381,230 | -327,760,773 |
| Profit Margin | -20.6% | -19.6% | -22.5% |
| EBITDA | -65,057,850 | -50,350,270 | -326,178,396 |
| Free Cash Flow | — | — | -164,017,098 |
| Rev Growth | +22.8% | +22.8% | +7.9% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |